FDA — authorised 3 August 1988
- Application: NDA018749
- Marketing authorisation holder: MISSION PHARMA
- Indication: Labeling
- Status: approved
🇺🇸 Lithostat in United States
FDA authorised Lithostat on 3 August 1988
Marketing authorisation
Lithostat in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Lithostat approved in United States?
Yes. FDA authorised it on 3 August 1988.
Who is the marketing authorisation holder for Lithostat in United States?
MISSION PHARMA holds the US marketing authorisation.